NorthWest Biotherapeutics Inc (NWBO)

[Truthfan]

From the Medivate Partners website - Portfolio listing

Medivate Partners was one of the principals in the management buyout in February 2018:

Cognate[color=red][/color]
homepage | https://www.cognatebioservices.com/
Cognate BioServices, Inc. is one of four well established contract manufacturing organizations (CMO) in the United States, with expertise in the clinical and commercial development, and manufacturing of cell therapies. Cognate is the only CMO to date capable of commercial scale manufacturing of cell therapies, with global No1. Capacity. Cognate has unparalleled experience in providing personalized immuno-oncology products in the largest PhIII cell- therapy clinical trial. With the
serif; font-size: 9pt;'>Cognate is the only CMO to date capable of commercial scale manufacturing of cell therapies, with global No1. Capacity. Cognate has unparalleled experience in providing personalized immuno-oncology products in the largest PhIII cell- therapy clinical trial.

With the recent FDA approval of the first cell-based/immuno-oncology therapeutics, (CAR-T), rapid expansion of the cell therapy market is expected.  Such favorable market dynamics will provide the cornerstone for Cognate’s further success

http://www.medivatepartners.com/en/html/current.html